pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked ·
766
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 1
naloxone
naloxone [INN]
Acute Opioid Overdosage
Taho Pharmaceuticals Ltd
0
catalysts
Phase 1
neldaleucel
Chronic Lymphocytic Leukemia (CLL)
$MRKR
Marker Therapeutics, Inc.
0
catalysts
Phase 1
nepicastat hydrochloride
Ulcerative Colitis
Asieris Pharmaceuticals (USA) Inc
0
catalysts
Phase 1
← prev
page 25 of 26
next →
131
Pain
89
Neurology
1
nicorandil ER
nicorandil
Chronic Stable Angina
Auxilius Pharma
0
catalysts
Phase 1
nitazoxanide
Alinia (nitazoxanide)
Acute On Chronic Liver Failure (ACLF)
Genfit SA
0
catalysts
Phase 1
norovirus [strain GI.1] vaccine
Norovirus Infections
$VXRT
Vaxart, Inc.
0
catalysts
Phase 1
oberotatug ravtansine
Adenoid Cystic Carcinoma (ACC)
Oxford BioTherapeutics Ltd
0
catalysts
Phase 1
oxymorphone ER
oxymorphone [INN]
Pain
Avecho Biotechnology Ltd
0
catalysts
Phase 1
pegmispotide
pegmispotide[INN]
Ulcerative Colitis
Adiso Therapeutics Inc
0
catalysts
Phase 1
pembrolizumab biosimilar
Melanoma
Formycon AG
0
catalysts
Phase 1
pemziviptadil
Vasomera (pemziviptadil [INN])
Cystic Fibrosis
ImmunoForge Co Ltd
0
catalysts
Phase 1
pidnarulex
pidnarulex [INN]
Prostate Cancer
Senhwa Biosciences Inc
0
catalysts
Phase 1
pinometostat
pinometostat [INN]
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)
Ipsen SA
0
catalysts
Phase 1
pioglitazone hydrochloride
Pioglitazone Hydrochloride (pioglitazone hydrochloride)
Nephrotic Syndrome
NephKey Therapeutics Inc
0
catalysts
Phase 1
pneumonic plaque vaccine
Pneumonic Plague
Wake Forest University
0
catalysts
Phase 1
potrasertib
potrasertib [INN]
Solid Tumor
IMPACT Therapeutics Inc
0
catalysts
Phase 1
pritumumab
pritumumab [INN]
Anaplastic Astrocytoma
Nascent Biotech Inc
0
catalysts
Phase 1
prosetin
Amyotrophic Lateral Sclerosis
Projenx Inc
0
catalysts
Phase 1
prulacabtagene leucel
B-Cell Non-Hodgkin Lymphoma
$ACET
Adicet Bio, Inc.
0
catalysts
Phase 1
quinine sulphate
Rhinosinusitis
GeneOne Life Science Inc
0
catalysts
Phase 1
ragistomig
ragistomig [INN]
Esophageal Cancer
$NBP
NovaBridge Biosciences
0
catalysts
Phase 1
rapaprutug
rapaprutug [INN]
Pulmonary Arterial Hypertension
Zymedi
0
catalysts
Phase 1
ratangratinib
ratangratinib [INN]
Bile Duct Cancer (Cholangiocarcinoma)
3D Medicines Inc
0
catalysts
Phase 1
remzistotug
Breast Cancer
$GSK
GSK plc
0
catalysts
Phase 1
rilogrotug
Cancer Anorexia-Cachexia Syndrome
AVEO Pharmaceuticals Inc
0
catalysts
Phase 1
rinzimetostat
rinzimetostat [INN]
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
$ORIC
Oric Pharmaceuticals, Inc.
0
catalysts
Phase 1
riztunitide
Amyotrophic Lateral Sclerosis
Neurodegenerative Disease Research Inc
0
catalysts
Phase 1
siremadlin succinate
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)
$NVS
NOVARTIS AG
0
catalysts
Phase 1
soralimixin sulfate
Acinetobacter Infections
Brii Biosciences Ltd
0
catalysts
Phase 1
sovilnesib
sovilnesib [INN]
Ovarian Cancer
Volastra Therapeutics Inc
0
catalysts
